# EDGAR Filing Document

**Accession Number:** 0001633214
**File Stem:** 0000892712-26-000023
**Filing Date:** 2026-1
**Character Count:** 12285
**Document Hash:** dc19db7d1864c23feb3adfcd3ea0bb13
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000892712-26-000023.hdr.sgml**: 20260105

**ACCESSION NUMBER**: 0000892712-26-000023

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260101

**FILED AS OF DATE**: 20260105

**DATE AS OF CHANGE**: 20260105

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Ferraro John Francis
- **CENTRAL INDEX KEY:** 0001633214

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10686
- **FILM NUMBER:** 26507584

**MAIL ADDRESS:**
- **STREET 1:** MANPOWERGROUP INC.
- **STREET 2:** 100 MANPOWER PLACE
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53212
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ManpowerGroup Inc.
- **CENTRAL INDEX KEY:** 0000871763
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 391672779
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 100 MANPOWER PLACE
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53212
- **BUSINESS PHONE:** 414 961-1000

**MAIL ADDRESS:**
- **STREET 1:** 100 MANPOWER PLACE
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53212

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MANPOWER INC /WI/
- **DATE OF NAME CHANGE:** 19930328

## Exhibit 24.1

Exhibit 24.1

**POWER OF ATTORNEY**

**For Executing Forms 3, 4 and 5 and 144**

Know all by these present, that the undersigned constitutes and appoints each of Jonas Prising, John T. McGinnis, Michelle Nettles, and Shannon Kobylarczyk, signing singly, his true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) execute for and on behalf of the undersigned notices on Form 144 in accordance with Rule 144 under the Securities Act of 1933;

(3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Forms 3, 4 or 5 or Form 144 and the timely filing of such forms with the United States Securities and Exchange Commission, any stock exchange or other authority; and

(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to the Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his or her discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation and hereby ratifies and confirms all that such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 and the rules thereunder or Rule 144 under the Securities Act of 1933. This Power of Attorney shall be a durable power of attorney and shall not be affected by subsequent disability or incapacity of the undersigned.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed effective as of the 22<sup>nd</sup> day of January 2025.

<u>/s/ John F. Ferraro</u>

John F. Ferraro

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Ferraro John Francis<br><sub>(Last) (First) (Middle)</sub><br>MANPOWERGROUP INC.<br>100 MANPOWER PLACE<br><sub>(Street)</sub><br>MILWAUKEE, WI 53212<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-01-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ManpowerGroup Inc. [ MAN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-01-01 |  | A<sup>(1)</sup> |  | 6054<sup>(2)</sup> | A | 29.73<sup>(3)</sup> | 17063 | D |  |
| Common Stock | 2026-01-01 |  | M |  | 1120 | A | <sup>(4)</sup> | 18183 | D |  |
| Common Stock | 2026-01-01 |  | M |  | 1628 | A | <sup>(4)</sup> | 19811 | D |  |
| Common Stock | 2026-01-01 |  | M |  | 2354 | A | <sup>(4)</sup> | 22165 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Deferred Stock Units | <sup>(7)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 74 |  | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 74 | 41.48<sup>(6)</sup> | 2214 | D |  |
| Deferred Stock Units | <sup>(8)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 55 |  | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 55 | 41.48<sup>(6)</sup> | 1628 | D |  |
| Deferred Stock Units | <sup>(9)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 104 |  | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 104 | 41.48<sup>(6)</sup> | 3096 | D |  |
| Deferred Stock Units | <sup>(10)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 74 |  | <sup>(10)</sup> | <sup>(10)</sup> | Common Stock | 74 | 41.48<sup>(6)</sup> | 2206 | D |  |
| Deferred Stock Units | <sup>(7)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 77 |  | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 77 | 41.48<sup>(6)</sup> | 2303 | D |  |
| Deferred Stock Units | <sup>(8)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 79 |  | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 79 | 41.48<sup>(6)</sup> | 2354 | D |  |
| Deferred Stock Units | <sup>(8)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 38 |  | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 38 | 41.48<sup>(6)</sup> | 1120 | D |  |
| Deferred Stock Units | <sup>(9)</sup> | 2026-01-01 |  | A<sup>(5)</sup> |  | 55 |  | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 55 | 41.48<sup>(6)</sup> | 1639 | D |  |
| Deferred Stock Units | <sup>(8)</sup> | 2026-01-01 |  | M |  |  | 1120 | 2026-01-01 | 2026-01-01 | Common Stock | 1120 | <sup>(4)</sup> | 0 | D |  |
| Deferred Stock Units | <sup>(8)</sup> | 2026-01-01 |  | M |  |  | 1628 | 2026-01-01 | 2026-01-01 | Common Stock | 1628 | <sup>(4)</sup> | 0 | D |  |
| Deferred Stock Units | <sup>(8)</sup> | 2026-01-01 |  | M |  |  | 2354 | 2026-01-01 | 2026-01-01 | Common Stock | 2008 | <sup>(4)</sup> | 0 | D |  |

---

### Footnotes:

(1) Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions").

(2) The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter in 2026.

(3) Represents the Market Price (as defined in the Plan) on the last trading day of 2025.

(4) Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis.

(5) Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends.

(6) Represents the Average Trading Price (as defined in the Terms and Conditions).

(7) The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2029 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions.

(8) The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2026.

(9) The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions.

(10) The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2028 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions.

**Signature:** /s/ Michelle Nettles (pursuant to Power of Attorney previously filed)  
**Date:** 2026-01-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**